BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7700045)

  • 1. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.
    Topley N; Williams JD
    Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritonitis: pathophysiology and local defense mechanisms.
    Heemken R; Gandawidjaja L; Hau T
    Hepatogastroenterology; 1997; 44(16):927-36. PubMed ID: 9261580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity.
    Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD
    Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritoneal function and peritonitis in patients on peritoneal dialysis.
    Friedlander M
    J Lab Clin Med; 1993 Dec; 122(6):639-40. PubMed ID: 8245682
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of peritoneal dialysis on cytokine production by peritoneal cells.
    Topley N; Williams JD
    Blood Purif; 1996; 14(2):188-97. PubMed ID: 8785035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal host defense mechanisms in peritoneal dialysis.
    Holmes CJ
    Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043
    [No Abstract]   [Full Text] [Related]  

  • 7. The peritoneal immune system and continuous ambulatory peritoneal dialysis.
    Rapoport J; Hausmann MJ; Chaimovitz C
    Nephron; 1999; 81(4):373-80. PubMed ID: 10357643
    [No Abstract]   [Full Text] [Related]  

  • 8. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability.
    Zemel D; Krediet RT
    Blood Purif; 1996; 14(2):198-216. PubMed ID: 8785036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal permeability and encapsulating peritonitis.
    Verger C; Celicout B
    Lancet; 1985 Apr; 1(8435):986-7. PubMed ID: 2859446
    [No Abstract]   [Full Text] [Related]  

  • 14. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal membrane failure as a determinant of the CAPD future. An epidemiological, functional and pathological study.
    Huarte-Loza E; Selgas R; Carmona AR; Martinez ME; Muñoz J; Fontan MP; Ortega O; Escuin F; Sicilia LS
    Contrib Nephrol; 1987; 57():219-29. PubMed ID: 3677696
    [No Abstract]   [Full Text] [Related]  

  • 17. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
    Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
    Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
    Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report of encapsulating peritoneal sclerosis: the interpretation of functional and structural peritoneal changes.
    Diaz-Buxo JA
    Blood Purif; 2008; 26(1):12-7. PubMed ID: 18182789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal fungal peritonitis by Trichoderma longibrachiatum complicating peritoneal dialysis.
    Tanis BC; van der Pijl H; van Ogtrop ML; Kibbelaar RE; Chang PC
    Nephrol Dial Transplant; 1995; 10(1):114-6. PubMed ID: 7724005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.